Company intelligence / Profile preview

OpenEvidence

Cambridge, Massachusetts, United Statesopenevidence.com ↗

Ownership: Private
Employees: ~19
Development stage: Commercial

Overview

OpenEvidence offers an AI-enabled medical copilot that aggregates and synthesizes clinical evidence to support doctors in making evidence-based decisions at the point of care. The platform has demonstrated high accuracy on clinical exams such as the USMLE and outperforms general-purpose LLMs in producing actionable responses to clinical questions. It has strategic partnerships with leading journals like The New England Journal of Medicine and serves hundreds of thousands of verified doctors across over 10,000 care centers in the U.S.

Industry: Digital Health Medical Devices

Partnerships

NEJM Group / New England Journal of MedicineMayo Clinic Platform Accelerate program

Beyond the preview

Go deeper on OpenEvidence.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on OpenEvidence.

Explore the full profile